The proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritis
Open accessThe DOI matches its Crossref record; 69 of the 70 references it cites were found in a registry or an index.
Abstract
CXCL13 is a key B cell chemoattractant and marker of disease activity in patients with SLE; however, the mechanism of its induction has not been identified yet. Here, we have shown that the proteoglycan biglycan triggers CXCL13 expression via TLR2/4 in macrophages and dendritic cells. In vivo, levels of biglycan were markedly elevated in the plasma and kidneys of human SLE patients and lupus-prone (MRL/lpr) mice. Overexpression of soluble biglycan in MRL/lpr mice raised plasma and renal levels of CXCL13 and caused accumulation of B cells with an enhanced B1/B cell ratio in the kidney, worsening of organ damage, and albuminuria. Importantly, biglycan also triggered CXCL13 expression and B cell infiltration in the healthy kidney. Conversely, biglycan deficiency improved systemic and renal outcome in lupus-prone mice, with lower levels of autoantibodies, less enlargement of the spleen and lymph nodes, and reduction in renal damage and albuminuria. This correlated with a marked decline in circulating and renal CXCL13 and a reduction in the number of B cells in the kidney. Collectively, our results describe what we believe to be a novel mechanism for the regulation of CXCL13 by biglycan, a host-derived ligand for TLR2/4. Blocking biglycan-TLR2/4 interactions might be a promising strategy for the management of SLE and other B cell-mediated inflammatory disease entities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Innate immune cells also recognize glycans released from tissue damage in vertebrates such as hyaluronan fragments (467, 914 -915) and some matrix proteoglycans (956 -957) as danger-associated molecular patterns (DAMPs) or ' alarmins ' , triggering responses similar to those generated by exogenous PAMPs”
From Biological roles of glycans (2017) · cites this paper as [956]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hochberg, M. C. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400928 · Cited by 11,409
Lawrence, R. C., Felson, D. T., Helmick, C. G., Arnold, L. M., Choi, H., Deyo, R. A., Gabriel, S., Hirsch, R., Hochberg, M. C., Hunder, G. G., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23176 · Cited by 5,499
Derivation of the sledai. A disease activity index for lupus patients
Bombardier, C., Gladman, D. D., Urowitz, M. B., Caron, D., Chang, C. H., Austin, A., Bell, A., Bloch, D. A., Corey, P. N., Decker, J. L., et al. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780350606 · Cited by 4,570
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part I
Helmick, C. G., Felson, D. T., Lawrence, R. C., Gabriel, S., Hirsch, R., Kwoh, C. K., Liang, M. H., Kremers, H. M., Mayes, M. D., Merkel, P. A., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23177 · Cited by 2,058
Rahman, A., & Isenberg, D. A. (2008) · New England Journal of Medicine · doi:10.1056/nejmra071297 · Cited by 1,632
Förster, R., Mattis, A. E., Kremmer, E., Wolf, E., Brem, G., & Lipp, M. (1996) · Cell · doi:10.1016/s0092-8674(00)81798-5 · Cited by 1,129
Rahman, M. U. (2008) · Essentials of Physical Medicine and Rehabilitation · doi:10.1016/b978-1-4160-4007-1.50153-x · Cited by 1,019
Martin, F., Oliver, A. M., & Kearney, J. F. (2001) · Immunity · doi:10.1016/s1074-7613(01)00129-7 · Cited by 985
Schaefer, L., Babelova, A., Kiss, E., Hausser, H.-J., Baliova, M., Krzyzankova, M., Marsche, G., Young, M. F., Mihalik, D., Götte, M., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23755 · Cited by 850
Self-citationTLR4 activation mediates kidney ischemia/reperfusion injury
Wu, H., Chen, G., Wyburn, K. R., Yin, J., Bertolino, P., Eris, J. M., Alexander, S. I., Sharland, A. F., & Chadban, S. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31008 · Cited by 836
Cited by
Items 101–200 of 207
Potula, H.-H. S. K., Xu, Z., Zeumer, L., Sang, A. L., Croker, B. P., & Morel, L. M. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200556 · Cited by 29
“they can class-switch and secrete anti-dsDNA IgG (7, 8).”
BackgroundThe Role of Hyaluronan and CD44 in the Pathogenesis of Lupus Nephritis
Yung, S., & Chan, T. M. (2012) · Autoimmune Diseases · doi:10.1155/2012/207190 · Cited by 28
“An important step in the initiation and propagation of lupus nephritis is the recruitment of immune cells, namely T cells, B cells, macrophages, and dendritic cells, to sites of injury including the kidney [57–62].”
CXCL13 Neutralization Attenuates Neuropsychiatric Manifestations in Lupus-Prone Mice
Huang, M. W., Stock, A. D., & Putterman, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.763065 · Cited by 27
“that looked at renal disease in MRL/lpr mice (64).”
BackgroundBolton, K. A., Segal, & Walder (2012) · Biologics · doi:10.2147/btt.s27925 · Cited by 27
Innate immune recognition receptors and damage-associated molecular patterns in plaque inflammation
Lundberg, A. M., & Yan, Z.-Q. (2011) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32834ada80 · Cited by 27
Kim, J., Lee, S. K., Shin, J., Jeoun, U., Jang, Y. J., Park, H. S., Kim, J.-H., Gong, G., Lee, T. J., Hong, J. P., et al. (2016) · Scientific Reports · doi:10.1038/srep30609 · Cited by 28
“Unsequestered biglycan can bind to macrophage toll-like receptors (TLRs) 2 and 4, thereby inducing secretion of proinflammatory cytokines such as tumor necrosis factor α (TNF-α ) 12–15 and IL-1 β 12 .”
Luque, A., Serrano, I., Ripoll, È., Malta, C. F., Gomà, M., Blom, A. M., Grinyo, J. M., de Córdoba, S. R., Torrás, J., & Aran, J. M. (2019) · Kidney International · doi:10.1016/j.kint.2019.10.016 · Cited by 25
Complexity of matrix phenotypes
Iozzo, R. V., Theocharis, A. D., Neill, T., & Karamanos, N. K. (2020) · Matrix Biology Plus · doi:10.1016/j.mbplus.2020.100038 · Cited by 29
Matrix proteoglycans in tumor inflammation and immunity
Deb, G., Cicala, A., Papadas, A., & Asimakopoulos, F. A. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00023.2022 · Cited by 28
Peek, V., Neumann, E., Inoue, T., Koenig, S., Pflieger, F. J., Gerstberger, R., Roth, J., Matsumura, K., & Rummel, C. D. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01800 · Cited by 26
“, during systemic lupus erythematosus to more than 1μg/ml (104)].”
BackgroundColes, C. A., Gordon, L., Hunt, L. C., Webster, T., Piers, A. T., Kintakas, C., Woodman, K. G., Touslon, S. L., Smythe, G. M., White, J. D., et al. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz266 · Cited by 20
Biglycan: a promising new therapeutic for neuromuscular and musculoskeletal diseases
Young, M. F., & Fallon, J. R. (2012) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2012.07.008 · Cited by 21
Self-citationMiguez, P. A., Bash, E., Musskopf, M. L., Tuin, S. A., Rivera-Concepcion, A., Chapple, I., & Liu, J. (2023) · Periodontology 2000 · doi:10.1111/prd.12515 · Cited by 21
Kunnathattil, M., Rahul, P., & Skaria, T. (2023) · Immunology and Cell Biology · doi:10.1111/imcb.12712 · Cited by 24
“128 Collectively, these signaling pathways may stimulate a proinflammatory response in inflammatory diseases.”
BackgroundThe Course of Myasthenia Gravis with Systemic Lupus Erythematosus
Bekircan‐Kurt, C. E., Kurne, A., Erdem‐Özdamar, S., Kalyoncu, U., Karabudak, R., & Tan, E. (2014) · European Neurology · doi:10.1159/000365568 · Cited by 20
Pawar, R. D., Goilav, B., Xia, Y., Herlitz, L., Doerner, J., Chalmers, S. A., Ghosh, K., Zang, X., & Putterman, C. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12452 · Cited by 20
Frey, H., Moreth, K., Hsieh, L. T.-H., Zeng-Brouwers, J., Rathkolb, B., Fuchs, H., Gailus‐Durner, V., Iozzo, R. V., de Angelis, M. H., & Schaefer, L. (2016) · Glycoconjugate Journal · doi:10.1007/s10719-016-9722-y · Cited by 22
“Biglycan from the kidney and liver homogenates as well as plasma samples (n = 3 for each group) was extracted and semi-purified as described previously [25, 33].”
BackgroundMethodSelf-citationZeng, Y., Zhang, Y., Lin, Y., Wang, X., Chen, Q., Huang, Q., Wang, J., Jiang, L., & Xiao, Y. (2021) · Clinical and Experimental Medicine · doi:10.1007/s10238-021-00707-x · Cited by 22
Pawar, R. D., Goilav, B., Xia, Y.-M., Zhuang, H.-Y., Herlitz, L., Reeves, W., & Putterman, C. (2014) · Clinical Immunology · doi:10.1016/j.clim.2014.06.007 · Cited by 22
Lindblom, J., Beretta, L., Borghi, M. O., Alarcón-Riquelme, M. E., & Parodis, I. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1257085 · Cited by 21
Small leucine-rich proteoglycans (SLRPs): characteristics and function in the intervertebral disc
Chen, L., Liao, J., Klineberg, E. O., Leung, V., & Huang, S. (2015) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2067 · Cited by 19
“Eventually, the chondrocytes of the IVD may be unable to continue the production of ECM and maintain the homeostasis of the whole IVD (Schonherr et al., 1998; Moreth et al., 2010).”
BackgroundSamson, N., & Paulin, R. (2017) · Pulmonary Circulation · doi:10.1177/2045893217714463 · Cited by 24
“In the pressure-overloaded RV, several chemokines are upregulated (CXCL10, CXCL6, CX3CL1, CCL5, CXCL16, and CCL2(130)) and stimulate the expression of small leucine rich-proteoglycans (SLRP), which are recognized to act as signaling molecules and directly regulate inflammatory processes.(131,132)”
BackgroundZhao, C., Quan, X., He, J., Zhao, R., Zhang, Y., Li, X., Sun, S., Ma, R., & Zhang, Q. (2020) · Scientific Reports · doi:10.1038/s41598-020-60714-y · Cited by 18
A review on Tsukushi: mammalian development, disorders, and therapy
Istiaq, A., & Ohta, K. (2022) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-022-00669-z · Cited by 19
Proteoglycan and Collagen Degradation in Osteoarthritis
Gauci, S. J., Stanton, H., Little, C. B., & Fosang, A. (2017) · Springer eBooks · doi:10.1007/978-3-319-45803-8_3 · Cited by 26
Rettig, T. A., Harbin, J. N., Harrington, A., Dohmen, L., & Fleming, S. D. (2015) · Clinical Immunology · doi:10.1016/j.clim.2015.06.012 · Cited by 18
Rohm, I., Grün, K., Müller, L. M., Bäz, L., Förster, M., Schrepper, A., Kretzschmar, D., Pistulli, R., Yılmaz, A., Bauer, R., et al. (2019) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-180529 · Cited by 18
“Nevertheless, some cytokines, e.g., Cxcl 10, Cxcl6 or Cxcl16, could be shown to be up regulated in right ventricle confronted with pressure overload and mediate an increased expression of small leucine rich proteoglycans (SLRP), which are known to directly regulate inflammation [7, 47, 48].”
Sensing sterile injury: Opportunities for pharmacological control
Menezes, G. B., Mansur, D. S., McDonald, B., Kubes, P., & Teixeira, M. M. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.07.002 · Cited by 18
Kiripolsky, J., Kasperek, E. M., Zhu, C., Li, Q., Wang, J., Yu, G., & Kramer, J. M. (2021) · Journal of Autoimmunity · doi:10.1016/j.jaut.2021.102608 · Cited by 19
“Of note, IL-1β, MIP-1α, and RANTES were decreased and increased levels of IL-10 and MCP-1 were observed in supernatant derived from salivary gland lysates from NOD.”
BackgroundGraft rejection – endogenous or allogeneic?
Critchley, W. R., & Fildes, J. E. (2012) · Immunology · doi:10.1111/j.1365-2567.2012.03560.x · Cited by 17
The Involvement of Alarmins in the Pathogenesis of Sjögren’s Syndrome
Sarrand, J., Baglione, L., Parisis, D., & Soyfoo, M. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105671 · Cited by 17
Merline, R., Roedig, H., Zeng-Brouwers, J., Poluzzi, C., Tascher, G., Michaelis, J. B., López-Mosqueda, J., Rhiner, A., Huber, L. S., Diehl, V., et al. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00493.2022 · Cited by 17
Self-citationNovel roles of Tsukushi in signaling pathways and multiple disease processes
Deng, X., Li, Y., Guo, C. Y., Zhao, Z., & Yuan, G. (2021) · BioFactors · doi:10.1002/biof.1723 · Cited by 17
“In recent years, more and more studies have found that SLRPs were involved in regulating multiple signaling pathways that control cell proliferation, differentiation, immunity, inflammation, metabolism, and so on.(6,9,17,22,24,32) Previous studies have suggested that possible mechanisms of action include: (a) structur…”
BackgroundKiripolsky, J., Kasperek, E. M., Zhu, C., Li, Q., Wang, J., Yu, G., & Kramer, J. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.692216 · Cited by 15
“Of relevance to the current study, select pathways activated by Bgn require Myd88 (7, 42, 45, 46).”
BackgroundNakamura, T., Bonnard, B., Palacios, R., Fernández‐Celis, A., Jaisser, F., & López‐Andrés, N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126680 · Cited by 14
“In vivo, biglycan overexpression increases renal leukocyte infiltration, mainly that of macrophages and T cells [24,25].”
BackgroundInfluentialKemberi, M., Minns, A. F., & Santamaria, S. (2024) · Proteoglycan Research · doi:10.1002/pgr2.70011 · Cited by 17
Expression and prognostic analysis of BGN in head and neck squamous cell carcinoma
Zhao, L., Liang, J., Zhong, W., Han, C., Liu, D., & Chen, X. (2022) · Gene · doi:10.1016/j.gene.2022.146461 · Cited by 14
Tang, T., Thompson, J. C., Wilson, P. G., Nelson, C., Williams, K. J., & Tannock, L. R. (2012) · Connective Tissue Research · doi:10.3109/03008207.2012.715700 · Cited by 13
“In a murine lupus nephritis model, BGN deficiency was also found to improve renal outcome by reducing albuminuria, pro-inflammatory cytokine expression, and histological lesions, possibly through regulating the B cell chemoattractant CXCL13 [46].”
BackgroundImmunopathogenesis of Sjogren's syndrome: Current state of DAMPs
Ming, B., Zhu, Y., Zhong, J., & Dong, L. (2022) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2022.152062 · Cited by 15
Eichhorst, A., Daniel, C., Rzepka, R., Sehnert, B., Nimmerjahn, F., Voll, R. E., & Chevalier, N. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133234 · Cited by 14
Contribution of B‐1a cells to systemic lupus erythematosus in the NZM2410 mouse model
Xu, Z., & Morel, L. M. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12607 · Cited by 15
Small leucine rich proteoglycans in host immunity and renal diseases
Zou, W., Wan, J., Li, M., Xing, J., Chen, Q., Zhang, Z., & Gong, Y. (2018) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-018-0489-8 · Cited by 12
Up-regulation of chemokine CXCL13 in systemic candidiasis
Li, C., Cao, J., Wang, L., Jia, X., He, J., & Zhang, L. (2017) · Clinical Immunology · doi:10.1016/j.clim.2017.11.015 · Cited by 11
Biglycan as a mediator of proinflammatory response and target for MDS and sAML therapy
Vaxevanis, C., Bauer, M., Subbarayan, K., Friedrich, M., Massa, C., Biehl, K., Al‐Ali, H. K., Wickenhauser, C., & Seliger, B. (2022) · OncoImmunology · doi:10.1080/2162402x.2022.2152998 · Cited by 10
CXCR5 and TLR4 signals synergistically enhance non‐small cell lung cancer progression
Shin, J. H., Kim, M., Kim, J. Y., Kang, Y., Kim, D., Jeong, S., Chun, E., & Lee, K. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1547 · Cited by 10
Gao, R., Tang, J., Dong, Y., Ming, B., Yu, Z., Zhong, J., & Dong, L. (2022) · Modern Rheumatology · doi:10.1093/mr/roac034 · Cited by 11
Emerging roles for tumor stroma in antigen presentation and anti-cancer immunity
Papadas, A., Huang, Y., Cicala, A., Dou, Y., Fields, M., Gibbons, A., Hong, D., Lagal, D. J., Quintana, V., Rizo, A., et al. (2023) · Biochemical Society Transactions · doi:10.1042/bst20221083 · Cited by 9
Wong, C. C. Y., Gao, L. Y., Xu, Y., Chau, M. K. M., Zhang, D., Yap, D. Y. H., Ying, S. K., Lee, C. K., Yung, S., & Chan, T. M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1443153 · Cited by 9
Chung, I., Kim, S. A., Kim, S., Lee, J. O., Park, C. Y., Lee, J., Kang, J. M., Lee, J., Seo, I., Lee, H. J., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202002039rr · Cited by 9
Vesci, L., Carollo, V., Roscilli, G., Aurisicchio, L., Ferrara, F. F., Spagnoli, L. G., & Santis, R. D. (2015) · Oncology Reports · doi:10.3892/or.2015.4074 · Cited by 9
“Moreover, the presence of ECM provides important differentiation cues, for example, by signalling via Toll-like receptors and integrins (22-24), thus further supporting the use of tissue slice method for screening of therapeutics.”
MethodHoermann, H., Krüger, I., Maurus, N., Reusswig, F., Sun, Y. E., Kohlmorgen, C., Grandoch, M., Fischer, J. W., & Elvers, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212168 · Cited by 8
“Interestingly, GPVI activation is also involved in ROS generation [36], suggesting that biglycan might be able to induce ROS production of platelets via GPVI.”
BackgroundInfluentialIntegrated bioinformatics analysis reveals novel key biomarkers in diabetic nephropathy
Joshi, H. R., Vastrad, B. M., Joshi, N., Vastrad, C. M., Vastrad, C. M., & Kotturshetti, I. (2022) · SAGE Open Medicine · doi:10.1177/20503121221137005 · Cited by 11
Toll-Like Receptor 2 or Toll-Like Receptor 4 Deficiency Does Not Modify Lupus in MRLlpr Mice
Freeley, S. J., Giorgini, A., Tulone, C., Popat, R. J., Horsfield, C. J., & Robson, M. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074112 · Cited by 8
“A recent report has demonstrated a role for biglycan in MRLlpr lupus [18].”
BackgroundPillai, V. S., Kundargi, R. R., Edathadathil, F., Nair, S., Thilak, J., Mathew, R. A., Xavier, T., Shenoy, P. D., & Menon, K. N. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.01.141 · Cited by 7
Mou, L., Lu, Y., Wu, Z., Pu, Z., Huang, X., & Wang, M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1391218 · Cited by 8
Unusual Suspects: Bone and Cartilage ECM Proteins as Carcinoma Facilitators
Sorvina, A., Antoniou, M., Esmaeili, Z., & Kochetkova, M. (2023) · Cancers · doi:10.3390/cancers15030791 · Cited by 7
“In addition to sequestering in the ECM, biglycan can exist as a soluble molecule upon cleavage from the ECM (proteolytic digestion or secreted by activated macrophages) that acts as a damage-associated molecular pattern (DAMP) protein [121].”
BackgroundOrigin, functions, heterogeneity and associated diseases of B-1 cells
Shen, W., Cui, S., Xia, Y., Duan, L., Dou, Y., Zhao, H., Liu, L. F., Wang, W., Cui, Y., Chen, Y., et al. (2025) · Clinical Immunology · doi:10.1016/j.clim.2025.110561 · Cited by 5
Yokoo, H., Koma, Y., Nomura, N., Torigoe, R., Omori, M., Nakanishi, T., Miyako, S., Nakanishi, T., Kodama, T., Shigeoka, M., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262412024 · Cited by 5
“Specifically, BGN induces CXCL13 expression in macrophages and dendritic cells [22].”
Small Leucine Rich Proteoglycan in Fibrotic Diseases: New Frenemies?
Guo, J., Wang, Y., Liang, H., & Yang, B. (2023) · International Journal of Drug Discovery and Pharmacology · doi:10.53941/ijddp.2023.100005 · Cited by 5
CXCL13/CXCR5 promote chronic postsurgical pain and astrocyte activation in rats by targeting NLRP3
Yi, H., Zhu, B., Zheng, C., Ying, Z., & Cheng, M. (2024) · Neuroreport · doi:10.1097/wnr.0000000000002023 · Cited by 5
“To date, there are no direct evidences for the cause-and-effect association between CXCL13 and NLRP3 in CPSP. Bird et al . and Moreth et al . have reported that in systemic lupus erythematosus mice, biglycan activates NLRP3 inflammasome and promotes IL-1 β production and CXCL13 expression [11,27].”
BackgroundRojas-Rivera, J. E., Hasegawa, T., Juarez, G. M. F., Praga, M., Saruta, Y., Fernández‐Fernández, B., Ortíz, A., Egido, J., Praga, M., Rodríguez-Moreno, A., et al. (2024) · Clinical Kidney Journal · doi:10.1093/ckj/sfae239 · Cited by 5
Zhang, C., Tam, T. W., Chau, M. K. M., Córdoba, C. A. G., Yung, S., & Chan, T. M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.866077 · Cited by 5
“…interstitial, and vascular areas were evaluated for glomerular hypercellularity, mesangial matrix expansion, crescent formation, influx of mononuclear cells, fibrinoid necrosis, hyaline deposits, tubular atrophy, protein cast deposition, and vasculopathy (Moreth et al., 2010; Yung et al., 2015b).”
BackgroundXu, W., Zhang, Y., & Ye, D. (2011) · Arthritis & Rheumatism · doi:10.1002/art.33356 · Cited by 5
Çakir, M. U., Karduz, G., & Aksu, U. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167745 · Cited by 5
Quantitative proteomic analysis of synovial tissue from rats with collagen-induced arthritis
Huang, W., Liang, Q.-H., Chen, J., Zhu, H., Xie, W., Wang, Y., Yang, B., Peng, W., & Xiong, X. (2015) · RSC Advances · doi:10.1039/c5ra18743e · Cited by 3
Evaluation of the In Vitro and In Vivo Effects of Biglycan in Innate Immunity
Zeng-Brouwers, J., Huber, L. S., Merline, R., Trebicka, J., Wygrecka, M., & Schaefer, L. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-2946-8_9 · Cited by 3
Self-citationLara, M. L., Carvalho, M. G., de Souza, F. F., Schmith, R. A., Codognoto, V. M., Vita, B. D., Freitas‐Dell’Aqua, C. D. P., Landim, F. D. C., & Alvarenga, M. L. (2023) · Biochimie · doi:10.1016/j.biochi.2023.03.004 · Cited by 3
Dissection of inflammatory processes using chemokine biology: Lessons from clinical models
Nelson, P. J., & Teixeira, M. M. (2012) · Immunology Letters · doi:10.1016/j.imlet.2012.04.011 · Cited by 3
Huber, L. S., Merline, R., Zeng-Brouwers, J., Vutukuri, R., Kraus, N., Ortiz, C., Guenther, S., Buhl, E. M., Hahnefeld, L., Gurke, R., et al. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00544.2025 · Cited by 3
Self-citationZhao, J., Bai, X., Zhou, C., Ouyang, Q., Zhang, X., Zhang, X., Zheng, X., Li, C., Shen, W., Li, Q., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-08852-9 · Cited by 2
“However, protein levels of these chemokines in the kidneys were not examined 31,49,52 .”
Qu, P., Wuest, T. R., Min, Y., Alevizos, I., Young, H. A., & Lin, P. C. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102559 · Cited by 2
Bird, L. (2010) · Nature reviews. Immunology · doi:10.1038/nri2911 · Cited by 2
Vatazin, A., Нестеренко, И. В., Zulkarnaev, A., & Shakhov, N. L. (2015) · Russian Journal of Transplantology and Artificial Organs · doi:10.15825/1995-1191-2015-1-147-156 · Cited by 3
“Таким образом обеспечивается миграция нейтрофилов, макрофагов, Т- и В-клеток в трансплантат [6, 8].”
Colineau, L., Laabei, M., Liu, G., Ermert, D., Lambris, J. D., Riesbeck, K., & Blom, A. M. (2020) · Matrix Biology Plus · doi:10.1016/j.mbplus.2020.100020 · Cited by 4
“Decorin protein concentrations are strongly increased in the plasma of septic individuals, while plasma biglycan levels are enhanced in patients suffering from lupus nephritis [19,32].”
BackgroundPeng, W., Li, S., Cao, J., Zhang, W., Chen, P., Guo, J., Zhang, J., Yang, S., Wu, L., Li, Y., et al. (2025) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5c00895 · Cited by 1
Soluble cytokines and chemokines in NSCLC: drivers of immune evasion and angiogenesis
Yang, L., Fan, Z., Wang, Z., & Zhou, D. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1699065 · Cited by 1
“Elevated IL-8 levels in individuals diagnosed with late-stage pulmonary carcinoma exhibit a strong correlation with enhanced lymphatic invasion and increased angiogenic activity within NSCLC (32).”
Sulfated Glycosaminoglycans in Inflammation
Nadanaka, S., & Kitagawa, H. (2026) · Advances in experimental medicine and biology · doi:10.1007/978-3-032-04153-1_14 · Cited by 1
Evidence for Existence of Endogenous TLR4 Ligands
Maru, Y. (2021) · Springer eBooks · doi:10.1007/978-981-16-1757-7_7 · Cited by 1
DAMP-mediated inflammation and regulated cell death in immunoinflammatory rheumatic diseases
Зиявдинович, С. М. (2022) · Medical Immunology (Russia) · doi:10.15789/1563-0625-dmi-2557 · Cited by 2
Joshi, H. R., Vastrad, B. M., Joshi, N., Tengli, A., Vastrad, C. M., & Kotturshetti, I. (2020) · Research Square · doi:10.21203/rs.3.rs-132705/v1 · Cited by 1
“SERPINA3 [41], IKZF1 [42], BTK (Bruton tyrosine kinase) [43], C1QA [44], CD1C [45] and CCL13 [46] have a key role in lupus nephritis, but these genes might be liable for advancement of DN. TNFSF14 [47], ITGAL (integrin subunit alpha L) [48], PLAC8 [49], ADRA2A [50], CCL21 [51], ALOX5 [52], CNR2 [53], COL1A1 [54], WNT7…”
BackgroundZeng, Y., Zhang, Y., Lin, Y., Wang, X., Chen, Q., Huang, Q., Wang, J., Jiang, L., & Xiao, Y. (2020) · doi:10.22541/au.160405570.08073821/v1 · Cited by 1
Borbely, A. U. (2013) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2013.tde-29052014-132134
Peri- and extravascular inflammation : impact on atherosclerosis
Daissormont, I. (2012) · Research Publications (Maastricht University) · doi:10.26481/dis.20120413id
Evidence for Existence of Endogenous TLR4 Ligands
Maru, Y. (2016) · Springer eBooks · doi:10.1007/978-4-431-56024-1_7
Mini-Review: Decorin, a Guardian from the Matrix
Neill, T., Schaefer, L., & Iozzo, R. V. (2012) · The Medicine Forum
Self-citationDo Proteoglycans Mediate Chronic Photoaging?
Oh, J., & Chung, J. H. (2019) · Royal Society of Chemistry eBooks · doi:10.1039/9781788015981-00231
Biology of Proteoglycans and Associated Glycosaminoglycans
Salinas-Marín, R., Villanueva-Cabello, T. M., & Martínez-Duncker, I. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819475-1.00065-1
Innate Immune Dysregulation in Sjögren’s Syndrome
Kiripolsky, J., & Kramer, J. M. (2021) · Springer eBooks · doi:10.1007/978-3-030-72029-2_5
Li, C., Maishi, N., Annan, D. A., Young, M. F., Morimoto, H., Morimoto, M., Nam, J.-M., Hida, Y., & Hida, K. (2021) · Research Square · doi:10.21203/rs.3.rs-142861/v1 · Cited by 1
Self-citationInflammation: Directions from the matrix
Bird, L. (2011) · Functional Glycomics · doi:10.1038/fg.2011.4
(2011) · Kidney International · doi:10.1038/ki.2011.11
Baghy, K., Reszegi, A., Horváth, Z., & Kovalszky, I. (2022) · Biology of extracellular matrix · doi:10.1007/978-3-030-99708-3_2 · Cited by 1
Small Leucine-Rich Proteoglycans Regulate Cancer Cell Growth, Apoptosis, and Associated Inflammation
Nikitovic, D., & Tzanakakis, G. N. (2022) · Biology of extracellular matrix · doi:10.1007/978-3-030-99708-3_1 · Cited by 2
ERO1α Promotes Tumorigenesis in EGFR Driven NSCLC
Johnson, B. D. (2022) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.11621
Serum asporin levels in maintenance hemodialysis patients without osteoarthritis
Dursun, A. D., & Demir, C. (2023) · Gulhane Medical Journal · doi:10.4274/gulhane.galenos.2022.97658
Myosin 16 mimicries may explain post- COVID-19 related neurological consequencesPreprint
Şahin, A., Babayev, H., Kurtoğlu, F. H., Morva, A., & Artaç, H. (2023) · Authorea · doi:10.22541/au.168450001.11449110/v1
SLRPs and Their Therapeutic Relevance
Lama, P. (2025) · Springer eBooks · doi:10.1007/978-981-96-7890-7_9
Li, C., Wu, F., Mao, J., Wang, Y., Zhu, J., Hong, K., Xie, H., Zhou, X., Tian, J., & Wen, C. (2024) · Figshare · doi:10.6084/m9.figshare.26322674
Cong, L., Maishi, N., Annan, D. A., Young, M. F., Morimoto, H., Morimoto, M., Nam, J.-M., Hida, Y., & Hida, K. (2021) · Figshare · doi:10.6084/m9.figshare.14562708
Self-citationCong, L., Maishi, N., Annan, D. A., Young, M. F., Morimoto, H., Morimoto, M., Nam, J.-M., Hida, Y., & Hida, K. (2021) · Figshare · doi:10.6084/m9.figshare.14562711
Self-citation
Metadata
- Authors
- Moreth, K., Brodbeck, R., Babelova, A., Gretz, N., Spieker, T., Zeng-Brouwers, J., Pfeilschifter, J., Young, M. F., Schaefer, R. M., & Schaefer, L.
- Affiliations
- Goethe University Frankfurt (DE)
- Heidelberg University (DE)
- University of Münster (DE)
- National Institutes of Health (US)
- Corresponding author
- Schaefer, Liliana
- Venue
- Journal of Clinical Investigation
- Published
- 2010-12-01
- Volume
- 120
- Issue
- 12
- Pages
- 4251-4272
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC2993585
- OpenAlex
- W1968712129
- Cited by
- 207
- References
- 70
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 10 · 2023: 11 · 2022: 20 · 2021: 22 · 2020: 13 · 2019: 15 · 2018: 8 · 2017: 12 · 2016: 8 · 2015: 18 · 2014: 15 · 2013: 14 · 2012: 18
- FWCI
- 9.37
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (GRK1172, Project A7, SFB 815, project A5)
- Else Kröner-Fresenius-Stiftung
- Goethe-Universität Frankfurt am Main
- National Institutes of Health (SFB 815)
- National Institute of Dental and Craniofacial Research
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Health Sciences › Medicine › Complementary and alternative medicine › Natural Compounds in Disease Treatment
- Keywords
- biglycan, CXCL13, systemic lupus erythematosus, lupus nephritis, TLR2/4 signaling, proteoglycans, macrophages, dendritic cells, MRL/lpr mice, albuminuria, autoantibodies
- MeSH terms
- Adolescent, Adult, Animals, B-Lymphocytes, Diabetic Nephropathies, Female, Graft Rejection, Humans, Kidney, Lupus Erythematosus, Systemic, Lupus Nephritis, Macrophages, Male, Mice, Inbred C57BL, Mice, Inbred NZB, T-Lymphocytes, Case-Control Studies, Cytokines, Mice, Knockout, Chemokines, Mice, Inbred MRL lpr, Toll-Like Receptor 2, Toll-Like Receptor 4, Mice, Chemokine CXCL13, Young Adult, Biglycan
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.